US Bancorp’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.6K | Sell |
1,022
-200
| -16% | -$13K | ﹤0.01% | 2648 |
|
|
2025
Q4 | $97.9K | Buy |
1,222
+764
| +167% | +$51.3K | ﹤0.01% | 2382 |
|
|
2025
Q3 | $22.3K | Sell |
458
-293
| -39% | -$18.1K | ﹤0.01% | 3032 |
|
|
2025
Q2 | $56K | Sell |
751
-135
| -15% | -$8.94K | ﹤0.01% | 2724 |
|
|
2025
Q1 | $56.3K | Buy |
886
+303
| +52% | +$20.6K | ﹤0.01% | 2693 |
|
|
2024
Q4 | $45.5K | Buy |
583
+132
| +29% | +$10.6K | ﹤0.01% | 2782 |
|
|
2024
Q3 | $36.3K | Sell |
451
-40
| -8% | -$3.23K | ﹤0.01% | 2891 |
|
|
2024
Q2 | $40.6K | Sell |
491
-18
| -4% | -$1.58K | ﹤0.01% | 2775 |
|
|
2024
Q1 | $43.4K | Sell |
509
-207
| -29% | -$16.2K | ﹤0.01% | 2773 |
|
|
2023
Q4 | $61.2K | Buy |
716
+38
| +6% | +$3.29K | ﹤0.01% | 2566 |
|
|
2023
Q3 | $60.7K | Sell |
678
-38
| -5% | -$3.39K | ﹤0.01% | 2346 |
|
|
2023
Q2 | $61K | Sell |
716
-72
| -9% | -$6.09K | ﹤0.01% | 2415 |
|
|
2023
Q1 | $65.2K | Sell |
788
-37
| -4% | -$3K | ﹤0.01% | 2386 |
|
|
2022
Q4 | $64.9K | Sell |
825
-196
| -19% | -$15.8K | ﹤0.01% | 2394 |
|
|
2022
Q3 | $76K | Sell |
1,021
-335
| -25% | -$24.1K | ﹤0.01% | 2310 |
|
|
2022
Q2 | $88K | Sell |
1,356
-627
| -32% | -$37.1K | ﹤0.01% | 2306 |
|
|
2022
Q1 | $126K | Sell |
1,983
-263
| -12% | -$14.3K | ﹤0.01% | 2178 |
|
|
2021
Q4 | $119K | Sell |
2,246
-1,068
| -32% | -$65.1K | ﹤0.01% | 2218 |
|
|
2021
Q3 | $233K | Buy |
3,314
+659
| +25% | +$41.6K | ﹤0.01% | 1902 |
|
|
2021
Q2 | $176K | Buy |
2,655
+83
| +3% | +$5.87K | ﹤0.01% | 2022 |
|
|
2021
Q1 | $285K | Sell |
2,572
-31
| -1% | -$3.84K | ﹤0.01% | 1770 |
|
|
2020
Q4 | $309K | Sell |
2,603
-85
| -3% | -$9.15K | ﹤0.01% | 1675 |
|
|
2020
Q3 | $234K | Sell |
2,688
-182
| -6% | -$15.9K | ﹤0.01% | 1700 |
|
|
2020
Q2 | $258K | Sell |
2,870
-678
| -19% | -$68.5K | ﹤0.01% | 1634 |
|
|
2020
Q1 | $354K | Buy |
3,548
+335
| +10% | +$36.3K | ﹤0.01% | 1394 |
|
|
2019
Q4 | $370K | Sell |
3,213
-58
| -2% | -$7.02K | ﹤0.01% | 1517 |
|
|
2019
Q3 | $412K | Sell |
3,271
-7
| -0.2% | -$888 | ﹤0.01% | 1465 |
|
|
2019
Q2 | $394K | Buy |
3,278
+159
| +5% | +$15.6K | ﹤0.01% | 1519 |
|
|
2019
Q1 | $273K | Sell |
3,119
-1,326
| -30% | -$121K | ﹤0.01% | 1661 |
|
|
2018
Q4 | $445K | Sell |
4,445
-2,334
| -34% | -$245K | ﹤0.01% | 1397 |
|
|
2018
Q3 | $777K | Sell |
6,779
-3,841
| -36% | -$398K | ﹤0.01% | 1234 |
|
|
2018
Q2 | $952K | Sell |
10,620
-8,962
| -46% | -$757K | ﹤0.01% | 1123 |
|
|
2018
Q1 | $1.43M | Sell |
19,582
-2,102
| -10% | -$144K | ﹤0.01% | 926 |
|
|
2017
Q4 | $1.26M | Sell |
21,684
-2,344
| -10% | -$123K | ﹤0.01% | 988 |
|
|
2017
Q3 | $1.08M | Buy |
24,028
+1,874
| +8% | +$77.9K | ﹤0.01% | 1046 |
|
|
2017
Q2 | $875K | Buy |
22,154
+141
| +0.6% | +$5.79K | ﹤0.01% | 1117 |
|
|
2017
Q1 | $893K | Buy |
22,013
+917
| +4% | +$35.8K | ﹤0.01% | 1128 |
|
|
2016
Q4 | $848K | Sell |
21,096
-267
| -1% | -$10.1K | ﹤0.01% | 1143 |
|
|
2016
Q3 | $774K | Sell |
21,363
-698
| -3% | -$24K | ﹤0.01% | 1158 |
|
|
2016
Q2 | $639K | Buy |
22,061
+3,704
| +20% | +$112K | ﹤0.01% | 1219 |
|
|
2016
Q1 | $642K | Buy |
18,357
+2,922
| +19% | +$94.4K | ﹤0.01% | 1192 |
|
|
2015
Q4 | $498K | Sell |
15,435
-1,618
| -9% | -$52.5K | ﹤0.01% | 1299 |
|
|
2015
Q3 | $551K | Sell |
17,053
-714
| -4% | -$26.9K | ﹤0.01% | 1254 |
|
|
2015
Q2 | $735K | Buy |
17,767
+216
| +1% | +$9.11K | ﹤0.01% | 1172 |
|
|
2015
Q1 | $788K | Buy |
17,551
+2,823
| +19% | +$118K | ﹤0.01% | 1136 |
|
|
2014
Q4 | $551K | Buy |
14,728
+558
| +4% | +$20.4K | ﹤0.01% | 1294 |
|
|
2014
Q3 | $495K | Sell |
14,170
-2,158
| -13% | -$77K | ﹤0.01% | 1323 |
|
|
2014
Q2 | $576K | Sell |
16,328
-584
| -3% | -$19.5K | ﹤0.01% | 1264 |
|
|
2014
Q1 | $551K | Sell |
16,912
-864
| -5% | -$33K | ﹤0.01% | 1283 |
|
|
2013
Q4 | $749K | Buy |
17,776
+230
| +1% | +$9.46K | ﹤0.01% | 1071 |
|
|
2013
Q3 | $700K | Sell |
17,546
-593
| -3% | -$24.9K | ﹤0.01% | 1049 |
|
|
2013
Q2 | $750K | Buy |
+18,139
| New | +$734K | ﹤0.01% | 963 |
|
Other funds holding HAE
VPM
VCM
RRAM
US Bancorp's HAE Position: Q1 2026 in Review
US Bancorp reduced its Haemonetics (HAE) stake by 16% in Q1 2026, selling an estimated $13K and leaving 1,022 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2648.
US Bancorp first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.43M in Q1 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- US Bancorp held 1,022 shares of Haemonetics worth $57.6K as of Q1 2026.
- US Bancorp sold 200 Haemonetics shares in Q1 2026, an estimated $13K.
- Haemonetics made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #2648 holding.
- US Bancorp first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- US Bancorp's Haemonetics position peaked at $1.43M in Q1 2018.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.